Clovis Oncology, Inc.
CLVSQ
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 58.32M | 94.58M | 122.24M | 143.43M | 171.95M |
| Total Receivables | 22.62M | 23.15M | 34.48M | 33.67M | 31.26M |
| Inventory | 11.42M | 13.23M | 14.50M | 13.69M | 17.28M |
| Prepaid Expenses | 3.66M | 6.12M | 8.73M | 4.07M | 7.63M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 6.19M | 5.20M | 5.59M | 3.23M | 2.56M |
| Total Current Assets | 102.21M | 142.28M | 185.54M | 198.09M | 230.67M |
|
|
|||||
| Total Current Assets | 102.21M | 142.28M | 185.54M | 198.09M | 230.67M |
| Net Property, Plant & Equipment | 21.52M | 23.15M | 24.66M | 25.66M | 27.18M |
| Long-term Investments | 63.07M | 63.07M | 63.07M | 63.07M | 63.07M |
| Goodwill | 63.07M | 63.07M | 63.07M | 63.07M | 63.07M |
| Total Other Intangibles | 56.34M | 57.69M | 59.03M | 60.37M | 61.71M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 103.63M | 106.67M | 119.23M | 125.64M | 125.36M |
| Total Assets | 346.78M | 392.86M | 451.53M | 472.83M | 508.00M |
|
|
|||||
| Total Accounts Payable | 18.12M | 24.23M | 22.33M | 27.31M | 23.83M |
| Total Accrued Expenses | 48.11M | 50.95M | 57.84M | 64.88M | 69.13M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 663.83M | 29.11M | 20.56M | 11.91M | 3.48M |
| Total Finance Division Other Current Liabilities | 17.81M | 16.99M | 21.10M | 21.12M | 16.26M |
| Total Other Current Liabilities | 17.81M | 16.99M | 21.10M | 21.12M | 16.26M |
| Total Current Liabilities | 747.87M | 121.27M | 121.83M | 125.21M | 112.69M |
|
|
|||||
| Total Current Liabilities | 747.87M | 121.27M | 121.83M | 125.21M | 112.69M |
| Long-Term Debt | -- | 621.38M | 614.00M | 606.73M | 599.54M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 16.79M | 17.90M | 19.00M | 19.73M | 20.61M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 625.00K |
| Total Liabilities | 764.66M | 760.55M | 754.84M | 751.67M | 733.46M |
|
|
|||||
| Common Stock & APIC | 2.69B | 2.68B | 2.68B | 2.64B | 2.63B |
| Retained Earnings | -3.06B | -3.01B | -2.94B | -2.88B | -2.81B |
| Treasury Stock & Other | -40.91M | -41.84M | -43.00M | -43.43M | -43.96M |
| Total Common Equity | -417.89M | -367.70M | -303.31M | -278.84M | -225.46M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -417.89M | -367.70M | -303.31M | -278.84M | -225.46M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -417.89M | -367.70M | -303.31M | -278.84M | -225.46M |
|
|
|||||
